These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 26344648)
21. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p. Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891 [TBL] [Abstract][Full Text] [Related]
22. Anticancer effects and potential mechanisms of ginsenoside Rh2 in various cancer types (Review). Zhang H; Park S; Huang H; Kim E; Yi J; Choi SK; Ryoo Z; Kim M Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649861 [TBL] [Abstract][Full Text] [Related]
23. MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target. Zhang S; Zhang Q; Shi G; Yin J Biomed Pharmacother; 2018 Jan; 97():1189-1194. PubMed ID: 29136958 [TBL] [Abstract][Full Text] [Related]
24. Ginsenoside Rh2 induces Bcl-2 family proteins-mediated apoptosis in vitro and in xenografts in vivo models. Choi S; Oh JY; Kim SJ J Cell Biochem; 2011 Jan; 112(1):330-40. PubMed ID: 21080338 [TBL] [Abstract][Full Text] [Related]
25. New insight into 20(S)-ginsenoside Rh2 against T-cell acute lymphoblastic leukemia associated with the gut microbiota and the immune system. Xia T; Zhang B; Li Y; Fang B; Zhu X; Xu B; Zhang J; Wang M; Fang J Eur J Med Chem; 2020 Oct; 203():112582. PubMed ID: 32682197 [TBL] [Abstract][Full Text] [Related]
26. Ginsenoside Rh2 enhances immune surveillance of natural killer (NK) cells via inhibition of ERp5 in breast cancer. Yang C; Qian C; Zheng W; Dong G; Zhang S; Wang F; Wei Z; Xu Y; Wang A; Zhao Y; Lu Y Phytomedicine; 2024 Jan; 123():155180. PubMed ID: 38043385 [TBL] [Abstract][Full Text] [Related]
27. Ginsenoside Rh2 stimulates the production of mitochondrial reactive oxygen species and induces apoptosis of cervical cancer cells by inhibiting mitochondrial electron transfer chain complex. Liu Y; Yu S; Xing X; Qiao J; Yin Y; Wang J; Liu M; Zhang W Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34713297 [TBL] [Abstract][Full Text] [Related]
28. Ginsenoside Rh2 inhibits metastasis of glioblastoma multiforme through Akt-regulated MMP13. Guan N; Huo X; Zhang Z; Zhang S; Luo J; Guo W Tumour Biol; 2015 Sep; 36(9):6789-95. PubMed ID: 25835975 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer. Wei C; Luo Q; Sun X; Li D; Song H; Li X; Song J; Hua K; Fang L Int J Clin Exp Pathol; 2015; 8(7):7729-39. PubMed ID: 26339338 [TBL] [Abstract][Full Text] [Related]
30. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells. Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745 [TBL] [Abstract][Full Text] [Related]
31. Ginsenoside Rh2 induces apoptosis independently of Bcl-2, Bcl-xL, or Bax in C6Bu-1 cells. Kim YS; Jin SH; Lee YH; Kim SI; Park JD Arch Pharm Res; 1999 Oct; 22(5):448-53. PubMed ID: 10549570 [TBL] [Abstract][Full Text] [Related]
32. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models. Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420 [TBL] [Abstract][Full Text] [Related]
33. 20(S)-Ginsenoside Rh2 displays efficacy against T-cell acute lymphoblastic leukemia through the PI3K/Akt/mTOR signal pathway. Xia T; Zhang J; Zhou C; Li Y; Duan W; Zhang B; Wang M; Fang J J Ginseng Res; 2020 Sep; 44(5):725-737. PubMed ID: 32913402 [TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cheng CC; Yang SM; Huang CY; Chen JC; Chang WM; Hsu SL Cancer Chemother Pharmacol; 2005 Jun; 55(6):531-40. PubMed ID: 15739095 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of prostatic cancer growth by ginsenoside Rh2. Zhang Q; Hong B; Wu S; Niu T Tumour Biol; 2015 Apr; 36(4):2377-81. PubMed ID: 25416441 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells. Tian C; Zheng G; Zhuang H; Li X; Hu D; Zhu L; Wang T; You MJ; Zhang Y J Cell Physiol; 2017 Jun; 232(6):1387-1395. PubMed ID: 27696394 [TBL] [Abstract][Full Text] [Related]
37. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis. Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095 [TBL] [Abstract][Full Text] [Related]
38. MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death. Ding C; Chen SN; Macleod RAF; Drexler HG; Nagel S; Wu DP; Sun AN; Dai HP Ups J Med Sci; 2018 Mar; 123(1):19-27. PubMed ID: 29493383 [TBL] [Abstract][Full Text] [Related]
39. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer. Yuan Z; Jiang H; Zhu X; Liu X; Li J Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544 [TBL] [Abstract][Full Text] [Related]
40. Effect of ginsenoside Rh-2 via activation of caspase-3 and Bcl-2-insensitive pathway in ovarian cancer cells. Kim JH; Choi JS Physiol Res; 2016 Dec; 65(6):1031-1037. PubMed ID: 27959575 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]